Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-7470917
  • Global Radiotherapy Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: August 2017 | Report Code: HME-7470917

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

The treatment of disease with ionizing radiation is known as radio therapy or radiation therapy. Radiotherapy use high-energy rays to treat disease, this therapy can be externally. Basically radiotherapy works for destroying cancer cells in the area that’s been affected; at the time of treatment usually normal cells can also be damaged by radiotherapy. Normal cells can recover after radiotherapy then cancer cells, as these cancer cells cannot repair themselves after radiotherapy.  G Global radiotherapy device market is expected to grow at a CAGR of 6.8% during the forecast period of 2016-2023. The key trends for the global radio therapy market are various technological advancements such as stereotactic body radiation therapy, advancements in proton therapy in the field of radiotherapy and rising adoption of key trending innovation of pencil bar scanning for cancer treatments , it has the ability to treat complex tumor cells while avoiding healthy tissues and critical structures. Pencil bar scanning is also known as spot scanning. The major driving factors for the radiotherapy market are rising incidence and prevalence of cancer, rising technological advancements in the field of radiotherapy, growing geriatric population as persons over 65 years reported for 60% of newly diagnosed malignancies and 70% of all cancer deaths, rising adoption of radiotherapy devices, procedures and increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy. The key restraining factors that affect the growth of global radiotherapy device market are lack of adequate healthcare infrastructure and lack of trained personnel. Apart from this, the major challenges present in the market are difficulties in visualizing tumors during radiation procedures and affordability and accessibility of treatment. However, to overcome these market challenges, key opportunities for the global radiotherapy device market are emerging markets and rising investments to meet the increased demand for cancer treatment.

Key driving factor for the global radiotherapy device market across the globe is rising incidence and prevalence of cancer. Cancer has a key influence on society and across the globe; factors that are responsible for causing cancer are genetic changes, radiations such as ultraviolet rays from sun, chemicals in tobacco smoke. According to the National Cancer Institute (NIH) in 2016 around 1685210 new cases of cancer were diagnosed in United States and 595690 people died from this disease. Thus rising incidence and prevalence of cancer will generate the need for radiotherapy treatments and procedure across the globe which grows the global radiotherapy device market across the globe.

Source: OBRC analysis

The report on global radiotherapy device market is classified on the basis of product, type, applications and end-user.

Products are classified further into:

  • External Beam Radiotherapy
  • Internal Beam Radiotherapy/Brachytherapy
  • Systemic Radiotherapy




Types are classified further into:

  • External Beam Radiotherapy
  • Internal Beam Radiotherapy
  • Systemic Radiotherapy




Applications are classified further into:

  • External Beam Radiation Therapy
  • Internal Beam Radiotherapy/Brachytherapy



End-Users are classified further into:

  • Hospitals
  • Cancer Research Institutes
  • Ambulatory & Radiotherapy Centers




The revenue for the above, application and end-user is specific to the Global Radiotherapy device market. However, the total revenue of these application and end-user in general has been excluded from the scope of the report.

The global radiotherapy device market has been geographically segmented into:

  • North America (US & Canada)
  • Asia Pacific (China, India, Japan, Australia, Rest of Asia Pacific)
  • Europe (UK, France, Germany, Rest of Europe)
  • Rest of the World (RoW)





Geographically, North America dominates the global radiotherapy device market in terms of revenue due to growing number of cancer cases, rising technological advancements in radiotherapy equipment, also increasing focus of key vendors on expanding their presence in North America. Moreover, Asia-Pacific is expected  to be the fastest growing region. Factors responsible for the growth in this region are improvements in healthcare infrastructure, increasing aging population and rising number of cancer cases in this region.

The global radiotherapy device market is segmented on the basis of product, type, applications and end-user segment. On the basis of product segment, the market is further classified into External beam radiotherapy, internal beam radiotherapy/brachytherapy and systemic radiotherapy. On the basis of type, the market is classified into external beam radiotherapy, internal beam radiotherapy and systemic radiotherapy. On the basis of application, the market is classified into external beam radiation therapy and internal beam radiotherapy/brachytherapy. However, on the basis of end-user the global radiotherapy device market is classified into hospitals, cancer research institutes and ambulatory & radiotherapy centers.

Some of the leading market players within Global radiotherapy device market are:

  • Varian Medical Systems, Inc.
  • Mitsubishi Electric Corporation
  • RaySearch Laboratories
  • Mevion Medical Systems, Inc
  • Ion Beam Applications(IBA)
  • Others







Merger & acquisition, partnership, collaboration and product launch are some of the strategies used by companies within Global Radiotherapy market. Of these, collaboration, and merger & acquisition are primary strategies adopted by companies for increasing their market share.

For example: On 20 June, 2016, Varian Medical Systems launched Spot ON, a proton therapy for the treatment of cancer. Spot ON is the software which will deliver information about system deployments, information about new technology and research from clinicians.

Company profiling showcased within Global radiotherapy device market offers detailed analysis on company’s product portfolio, strategic initiatives, competitive landscape, market share and SCOT analysis.

Key Reason to buy the report:

  • The report include market estimation forecast and analysis for the year 2016-2023
  • The report points out scenarios that can drive, challenge, and restraint Global Radiotherapy device market.
  • Company profiling within the report offers strategic initiatives, and market share analysis of major players within the market.
  • The report offers snapshot on recent regulatory and government policies impacting market growth for the forecast period.





How we are different from others:

At OBRC, our reports offer an extensive portfolio through completed market analysis along with market share, market size, and market segmentation. The DROC’s for the markets are well thought out and researched after consulting with industry experts. Global radiotherapy device market showcases market analysis through models like investment vs. adoption, see saw analysis, and so on. The report also provides overview on product application, adoption and decision support within each segment. The company profiling for each major players within the market is showcased via SCOT analysis.

Key findings of the Global Radiotherapy market:

  • Rising incidence and prevalence of cancer and rising adoption of radiotherapy devices and procedures are fuelling growth in global radiotherapy device market.
  • North America is anticipated to hold the highest revenue share in 2016.
  • Asia- Pacific is anticipated to be a fastest growing region due to rising number of cancer cases in this region, rapid growth in aging population and improvements in healthcare infrastructure.
  • Increasing government support.
  • Product launch is the key strategy adopted by the various market players of global radiotherapy device market.
  • Hospital dominates the end-user segment.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL RADIOTHERAPY DEVICE MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. TOTAL MARKET ANALYSIS
2.4.1. TOP 5 FINDINGS
2.4.2. TOP 5 OPPORTUNITY MARKETS
2.4.3. TOP 5 COMPANIES
2.4.4. TOP 3 COMPETITIVE STRATEGIES
2.5. ESTIMATION ANALYSIS
2.6. STRATEGIC ANALYSIS
2.6.1. INVESTMENT VS. ADOPTION MODEL
2.6.2. 360 DEGREE INDUSTRY ANALYSIS
2.6.3. PORTERS 5 FORCE MODEL
2.6.4. SEE-SAW ANALYSIS
2.6.5. ROI ANALYSIS
2.6.6. GAP ANALYSIS
2.6.7. PATENT ANALYSIS
2.6.8. PRICING ANALYSIS
2.6.9. PIPELINE ANALYSIS
2.6.10. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7. COMPETITIVE ANALYSIS
2.7.1. KEY STRATEGIES & ANALYSIS
2.7.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. RISNG TECHNOLOGICAL ADVANCEMENTS 
3.1.2. RISING INCIDENCE AND PREVALENCE OF CANCER 
3.1.3. RISING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES 
3.1.4. GROWING GERIATRIC POPULATION  
3.1.5. INCREASING NUMBER OF CONFERENCES AND SYMPOSIA FOCUSING ON SPREADING AWARENESS ABOUT THE BENEFITS OF RADIOTHERAPY
3.2. MARKET RESTRAINTS
3.2.1. LACK OF TRAINED PERSONNEL 
3.2.2. LACK OF ADEQUATE HEALTHCARE INFRASTRUCTURE 
3.3. MARKET OPPORTUNITIES
3.3.1. RISING  INVESTMENTS TO MEET THE INCREASIND DEMAND FOR CANCER TREATMENT 
3.3.2. EMERGING MARKETS 
3.4.  MARKET CHALLENGES 
3.4.1. AFFORDABILITY AND ACCESSIBILITY OF TREATMENT 
3.4.2. DIFFICULTIES IN VISUALIING TUMORS DURING RADIATION PROCEDURES 
 
4. MARKET SEGMENTATION 
4.1. GLOBAL RADIOTHERAPY DEVICE MARKET BY PRODUCT
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL EXTERNAL BEAM RADIOTHERAPY  MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL  INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL SYSTEMIC RADIOTHERAPY  MARKET 
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.3.4. KEY CONCLUSIONS
4.2. GLOBAL RADIOTHERAPY DEVICE MARKET BY TYPE 
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL EXETERNAL BEAM RADIOTHERAPY  MARKET
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. KEY PLAYERS & KEY PRODUCTS 
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL  INTERNAL BEAM RADIOTHERAPY  MARKET
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. KEY PLAYERS & KEY PRODUCTS 
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL SYSTEMIC RADIOTHERAPY   MARKET
4.2.5.3.1. APPLICATION
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. KEY PLAYERS & KEY PRODUCTS 
4.2.5.3.5. KEY CONCLUSIONS
4.3. GLOBAL RADIOTHERAPY DEVICE MARKET BY APPLICATION 
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL EXTERNAL BEAM RADIATION THERAPY  MARKET 
4.3.5.1.1. APPLICATION
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. KEY PLAYERS & KEY PRODUCTS 
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. GLOBAL INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY  MARKET 
4.3.5.2.1. APPLICATION
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4. KEY PLAYERS & KEY PRODUCTS 
4.3.5.2.5. KEY CONCLUSIONS
4.4. GLOBAL RADIOTHERAPY DEVICE MARKET BY END-USER 
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION 
4.4.5.1. GLOBAL  HOSPITALS   MARKET
4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.4.5.1.4. KEY CONCLUSIONS
4.4.5.2. GLOBAL  CANCER RESEARCH INSTITUTES  MARKET 
4.4.5.2.1. APPLICATION
4.4.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.4. KEY PLAYERS & KEY PRODUCTS 
4.4.5.2.5. KEY CONCLUSIONS
4.4.5.3. GLOBAL AMBULATORY & RADIOTHERAPY CENTERS MARKET 
4.4.5.3.1. APPLICATION
4.4.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.3.4. KEY PLAYERS & KEY PRODUCTS 
4.4.5.3.5. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGER & ACQUISITION
5.1.2. LIST OF JOINT VENTURE
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
5.2. TOP 10 COMPANY ANALYSIS
 
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL RADIOTHERAPY DEVICE MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. RUSSIA
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. ACCURAY INCORPORATED 
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. COVIDEN PLC OVERVIEW
7.2.1. OVERVIEW 
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS 
7.3. C.R. BARD , INC
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS 
7.3.5. STRATEGIC ANALYSIS
7.4. ELEKTA AB 
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. IBA (ION BEAM APPLICATIONS SA)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6.  MEVION MEDICAL SYSTEMS, INC 
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS 
7.6.5. STRATEGIC ANALYSIS
7.7. MITSUBISHI ELECTRIC CORPORATION 
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS 
7.7.5. STRATEGIC ANALYSIS
7.8. NORDIAN, INC 
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS 
7.8.5. STRATEGIC ANALYSIS
7.9. PANACEA MEDICAL TECHNOLOGIES PVT. LTD  
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS 
7.9.5. STRATEGIC ANALYSIS
7.10. P-CURE LTD 
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS 
7.10.5. STRATEGIC ANALYSIS
7.11. PRONOVA SOLUTIONS , LLC 
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. RAYSEARCH LABORATORIES 
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. THERAGENICS CORPORATION 
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. VARIAN MEDICAL SYSTEMS , INC 
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. VIEWRAY INC. 
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL RADIOTHERAPY DEVICE MARKET BY PRODUCT  2014-2023 ($ MILLION)
2. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL INTERNAL BEAM RADIOTHERAPY/ BRACHYTHERAPY  BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL SYSTEMIC RADIOTHERAPY  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL RADIOTHERAPY DEVICE MARKET BY TYPE  2014-2023 ($ MILLION)
6. GLOBAL EXTERNAL BEAM RADIOTHERAPY  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL INTERNAL BEAM RADIOTHERAPY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL SYSTEMIC RADIOTHERAPY  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
9. GLOBAL RADIOTHERAPY DEVICE MARKET BY APPLICATION 2014-2023 ($ MILLION)
10. GLOBAL EXTERNAL BEAM RADIATION THERAPY   MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL RADIOTHERAPY DEVICE MARKET BY END-USER  2014-2023 ($ MILLION)
13. GLOBAL HOSPITALS  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL  CANCER RESEARCH INSTITUTES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
15. GLOBAL AMBULATORY & RADIOTHERAPY CENTERS  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
16. NORTH AMERICA RADIOTHERAPY DEVICE  MARKET 2014-2023 ($ MILLION)
17. EUROPE DIGITAL RADIOTHERAPY DEVICE   MARKET 2014-2023 ($ MILLION)
18. ASIA PACIFIC DIGITAL RADIOTHERAPY DEVICE   MARKET 2014-2023 ($ MILLION)
19. REST OF THE WORLD RADIOTHERAPY DEVICE  MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL EXTERNAL BEAM RADIOTHERAPY  MARKET 2014-2023 ($ MILLION)
2. GLOBAL INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY  MARKET 2014-2023 ($ MILLION)
3. GLOBAL SYSTEMIC RADIOTHERAPY  MARKET 2014-2023 ($ MILLION)
4. GLOBAL EXTERNAL BEAM RADIOTHERAPY   MARKET 2014-2023 ($ MILLION)
5. GLOBAL INTERNAL BEAM RADIOTHERAPY  MARKET 2014-2023 ($ MILLION)
6. GLOBAL SYSTEMIC RADIOTHERAPY   MARKET 2014-2023 ($ MILLION)
7. GLOBAL EXTERNAL BEAM RADIATION THERAPY   MARKET 2014-2023 ($ MILLION)
8. GLOBAL INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY  MARKET 2014-2023 ($ MILLION)
9. GLOBAL HOSPITALS   MARKET 2014-2023 ($ MILLION)
10. GLOBAL  CANCER RESEARCH INSTITUTES   MARKET 2014-2023 ($ MILLION)
11. GLOBAL  AMBULATORY & RADIOTHERAPY CENTERS  MARKET  2014-2023 ($ MILLION)
12. UNITED STATES (U.S.) RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
13. CANADA RADIOTHERAPY DEVICE  MARKET 2014-2023 ($ MILLION)
14. UNITED KINGDOM (UK) RADIOTHERAPY DEVICE  MARKET 2014-2023 ($ MILLION)
15. FRANCE RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
16. GERMANY RADIOTHERAPY DEVICE  MARKET 2014-2023 ($ MILLION)
17. RUSSIA RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
18. ROE RADIOTHERAPY DEVICE  MARKET 2014-2023 ($ MILLION)
19. INDIA RADIOTHERAPY DEVICE  MARKET 2014-2023 ($ MILLION)
20. CHINA RADIOTHERAPY DEVICE  MARKET 2014-2023 ($ MILLION)
21. JAPAN RADIOTHERAPY  DEVICE MARKET 2014-2023 ($ MILLION)
22. AUSTRALIA RADIOTHERAPY DEVICE  MARKET 2014-2023 ($ MILLION)
23. ROAPAC RADIOTHERAPY DEVICE  MARKET 2014-2023 ($ MILLION)
24. LATIN AMERICA RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
25. MENA RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

Go To Top
viewthroughconversion